Myocarditis and Pericarditis

Angita Jain, Katelyn A. Bruno, Akira Matsumori, Leslie T. Cooper, Mohammad Yamani, De Lisa Fairweather

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myocarditis and pericarditis are defined as inflammation of the myocardium and pericardium, respectively, according to the current WHO classification. These diseases are usually self-limiting but may present with impaired cardiac function, arrhythmias or cardiogenic shock. This review discusses the management of myocarditis and pericarditis based on the current guidelines of the American College of Cardiology and the European Society of Cardiology. Treatment consists of specific therapy aimed at the cause (i.e., viral, fulminant, autoimmune) and nonspecific therapy aimed at the clinical manifestations such as heart failure or arrhythmias.

Original languageEnglish (US)
Title of host publicationComprehensive Pharmacology
PublisherElsevier
Pages413-431
Number of pages19
Volume4
ISBN (Electronic)9780128204726
DOIs
StatePublished - Jan 1 2022

Keywords

  • Autoimmune
  • COVID-19
  • Management
  • Myocarditis
  • Pathogenesis
  • Pericarditis
  • Therapy
  • Treatment
  • Virus

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Medicine

Fingerprint

Dive into the research topics of 'Myocarditis and Pericarditis'. Together they form a unique fingerprint.

Cite this